GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Revenue per Share

BDMD (Baird Medical Investment Holdings) Revenue per Share : $0.93 (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings Revenue per Share?

Baird Medical Investment Holdings's revenue per share for the six months ended in Jun. 2024 was $0.37. Baird Medical Investment Holdings's revenue per share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.93.

During the past 12 months, the average Revenue Per Share Growth Rate of Baird Medical Investment Holdings was 186.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Baird Medical Investment Holdings's Revenue per Share or its related term are showing as below:

BDMD's 3-Year Revenue Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.25
* Ranked among companies with meaningful 3-Year Revenue Growth Rate only.

Baird Medical Investment Holdings Revenue per Share Historical Data

The historical data trend for Baird Medical Investment Holdings's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings Revenue per Share Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23
Revenue per Share
0.78 0.99 0.89

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
Revenue per Share - - 0.33 0.56 0.37

Competitive Comparison of Baird Medical Investment Holdings's Revenue per Share

For the Medical Devices subindustry, Baird Medical Investment Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baird Medical Investment Holdings's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where Baird Medical Investment Holdings's PS Ratio falls into.


;
;

Baird Medical Investment Holdings Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Baird Medical Investment Holdings's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )=Revenue (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=31.458/35.450
=0.89

Baird Medical Investment Holdings's Revenue Per Share for the quarter that ended in Jun. 2024 is calculated as

Revenue Per Share (Q: Jun. 2024 )=Revenue (Q: Jun. 2024 )/Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
=13.137/35.450
=0.37

Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baird Medical Investment Holdings  (NAS:BDMD) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Baird Medical Investment Holdings Revenue per Share Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Baird Medical Investment Holdings Business Description

Traded in Other Exchanges
N/A
Address
No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN
Website
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.